Introduction
============

Despite the fact that autism was described more than 60 years ago, its etiology remains a mystery \[[@B1]-[@B5]\]. Many genetic studies \[[@B6]-[@B8]\], hormone and neurotransmitter analysis \[[@B9]-[@B15]\], did not find a reasonable explanation for the mechanisms underlying development of autism. Lesions of different brain regions, including the limbic system, have been implicated in the development of autism \[[@B12],[@B16]\]. The HPA axis deserves special attention, since it is the basis for emotions and social interactions, that are affected in autism \[[@B12],[@B13],[@B15],[@B17]\].

One of the approaches to test the HPA axis is a measurement of its hormones and their subsequent targets together with the rapid ACTH stimulation test \[[@B18],[@B19]\]. Studies regarding abnormalities in the HPA axis in autistic patients showed conflicting results \[[@B20]-[@B22]\].

With this background, this study was conducted to assess plasma cortisol (morning basal and ACTH stimulated), and ACTH levels in autistic children and adolescents and their relationship to disease characteristics in terms of disease severity, IQ, EEG abnormalities and self-aggressive behaviour.

Subjects and Methods
====================

This cross sectional case-control study was conducted on 50 autistic children and adolescents diagnosed according to the 4^th^edition of Diagnostic and Statistical Manual of Mental Disorders (DSM IV) \[[@B23]\]. Patients were recruited from the Institute of Psychiatry (n = 36) and Pediatric Psychiatry Clinic, Children\'s hospital (n = 14), Faculty of Medicine, Ain Shams University, Cairo, Egypt during the period from the beginning of May 2009 to the end of November 2009. They were 40 males and 10 females with a male: female ratio of 4:1. Their ages ranged between 3 and 12 years with a mean age of 7.35 ± 2.6 years. None of the patients had underlying conditions apart from autism (syndromic causes, chromosomal or metabolic abnormalities) that could influence HPA axis function independently of autism.

Autistic patients were studied in comparison to 50 healthy age-, sex- and pubertal stage- matched children and adolescents serving as controls. The latter had no clinical findings suggesting neuropsychiatric manifestations nor endocrine abnormalities in particular adrenocortical function (normal blood pressure, normal serum sodium, potassium and random blood sugar). None of the studied subjects were taking medications that might influence the HPA axis.

An informed written consent of participation in the study was signed by the parents or legal guardians of the studied subjects. This study was approved by the Bioethical Research Committee, Faculty of Medicine, Ain Shams University hospitals, Cairo, Egypt.

All studied children were subjected to
--------------------------------------

**1) Medical history**taken from the patients\' caregivers laying stress on developmental history and history suggestive of adrenocortical dysfunction e.g weakness, fatigue, anorexia, nausea, vomiting.

**2) Physical examination**especially hyperpigmentation of skin and/or mucous membranes (due to high ACTH) and Tanner staging for assessment of pubertal status according to the standards of Tanner and Whitehouse \[[@B24]\].

3\) Neuropsychiatric assessment (for patients only):

▪ Diagnosis of autism using DSM IV criteria \[[@B23]\].

▪ The severity of autism was evaluated using Childhood Autism Rating Scale \"CARS\" \[[@B25]\] which rates the child on a scale from one to four in each of 15 areas (relating to people; emotional response; imitation; body use; object use; listening response; fear or nervousness; verbal communication; non-verbal communication; activity level; level and consistency of intellectual response; adaptation to change; visual response; taste, smell and touch response and general impressions). According to the scale, scores of 30-36 indicate mild to moderate autism and scores of 37-60 indicate severe autism.

▪ **IQ assessment using Wechsler Intelligence Scale for Children (WISC):**\[[@B26]\]

Cognitive function (memory, attention, language, concept formation, problem solving, executive and visuospatial functions) was assessed with age-appropriate, translated and validated psychometric instruments that were administered by a well-trained psychologist. This scale is the most commonly used test to assess cognitive function in children. It measures verbal IQ (information and general knowledge, comprehension, arithmetic abilities, similarities to measure abstraction, vocabulary and digit span), performance IQ (picture completion for visuoperceptive defects, block design to measure left-right dominance, picture arrangement to measure subject\'s cognitive style, object assembly to measure organization and digit symbol) and full scale IQ. Subnormal intellectual function is diagnosed when IQ is below 70.

▪ History of self-aggressive behaviour including pulling their hair, ears and scratching their skin.

**4) Measurement of regional brain electrical activity of autistic children**. This was done by using inter-ictal EEG (for patients only).

5\) Laboratory investigations:

▪ Fasting morning plasma cortisol (9:00 am)

▪ Fasting morning plasma ACTH (9:00 am)

Plasma cortisol and ACTH were assayed by a single person blind to the clinical conditions of the patients using Siemens cortisol and ACTH kits with the Immulite 2000 Analyzer using chemiluminescent immunometric assay \[[@B27]\]. Reference age- and sex- matched values for basal plasma cortisol ranged between 7-25 ug/dl while those for plasma ACTH ranged between 10-48 pg/ml.

▪ Rapid ACTH stimulation test: A synthetic human ACTH is used, fasting is not required and the test can be performed at any time of the day. A baseline cortisol sample is obtained and ACTH is administered in a dose of 0.25 mg intravenously and another sample for plasma cortisol is obtained at 60 minutes following the injection. Normally, the plasma cortisol response at 60 minutes post injection should reach ≥ 18 ug/dl \[[@B18]\].

Statistical analysis
--------------------

The results were analyzed using the Statistical Package for the Social Science (SPSS) version number 10, Echosoft corp; USA, 2005. Description of quantitative variables was in the form of mean ± standard deviation and range while that of qualitative variables was in the form of frequency and percentage. Chi-square test was used to compare 2 qualitative data. Student\'s t-test of 2 independent samples was used to compare 2 quantitative variables while paired t-test was used to compare plasma cortisol levels before and after ACTH stimulation. Pearson correlation coefficient test (r-test) was used to rank different variables against each other either directly or indirectly. A p value of \< 0.05 was considered significant.

Results
=======

Of 50 studied patients, 29 (58%) were pre-pubertal, 13 (26%) were in Tanner stage 2, 7 (14%) were in Tanner stage 3 and 1 (2%) was in Tanner stage 4 which is earlier than what is normally expected for age because similar to the known combination of central nervous system disorders and precocious puberty, patients with autism may be susceptible to early onset of puberty \[[@B28]\]. Regarding autistic severity measured by CARS; 26 patients (52%) were of mild to moderate severity (18 males and 8 females) and 24 (48%) were severely autistic (22 males and 2 females).

None of our patients had history suggestive of adrenocortical dysfunction nor hyperpigmentation of the skin and/or mucous membranes. The mean values of all hormonal parameters among the whole sample were within normal reference ranges \[Table [1](#T1){ref-type="table"}\]. Eight patients (16%) had a higher plasma ACTH than age- and sex- matched reference ranges, 5/50 (10%) had a lower plasma cortisol than age- and sex- matched reference ranges and 5/50 (10%) did not show adequate cortisol response to ACTH stimulation, that is, a cortisol level of \< 18 ug/dl 60 minutes after ACTH injection. Autistic children had lower morning basal cortisol (p = 0.032), higher ACTH (p = 0.01) and lower cortisol response after ACTH stimulation (p = 0.04) when compared to healthy age-, sex- and pubertal stage- matched controls \[Table [1](#T1){ref-type="table"}\].

###### 

Comparison of basal and ACTH stimulated plasma cortisol, and ACTH levels among autistic patients and controls.

  --------------------------------------------------------------------------------------------------------
                                                       Patients         Controls          t      p
  ---------------------------------------------------- ---------------- ----------------- ------ ---------
  Morning basal cortisol\                              11.02 ± 5.23\    18.94 ± 3.05\     5.67   0.032\*
  (ug/dl)                                              (2.41-19.29)     (10.32-24.10)            

  Morning ACTH\                                        31.89 ± 10.17\   21.89 ± 6.15\     6.28   0.01\*
  (Pg/ml)                                              (18.82-56.24)    (12.67-34.21)            

  Cortisol 60 minutes after ACTH stimulation (ug/dl)   22.92 ± 3.12\    27.01 ± 2.19\     4.39   0.04\*
                                                       (14.38-28.08)    (18.23 ± 32.81)          
  --------------------------------------------------------------------------------------------------------

Results are expressed as mean± SD and range, p \< 0.05\*: significant, ACTH: adrenocorticotropic hormone.

Moreover, significantly lower morning basal cortisol (p = 0.041), higher ACTH (p = 0.033) and lower cortisol response after ACTH stimulation (p = 0.04) were encountered as the autistic severity increased \[Table [2](#T2){ref-type="table"}\]. In addition, CARS score correlated positively with ACTH (r = 0.71, p = 0.02) and negatively with each of basal cortisol (r = - 0.64, p = 0.04) and cortisol after ACTH stimulation (r = - 0.88, p \< 0.001, Figure [1](#F1){ref-type="fig"}).

###### 

Relationship between hormonal profile and autistic severity.

  ------------------------------------------------------------------------------
                            Mild to moderate\   Severe\         t      p
                            (n = 26)            (n = 24)               
  ------------------------- ------------------- --------------- ------ ---------
  Morning basal cortisol\   12.96 ± 4.28\       8.15 ± 4.14\    3.90   0.041\*
  (ug/dl)                   (5.32-19.29)        (2.41-16.32)           

  Morning ACTH\             26.94 ± 5.02\       33.83 ± 6.08\   4.32   0.033\*
  (Pg/ml)                   (18.82-49.61)       (20.89-56.24)          

  Cortisol 60 minutes\      23.42 ± 4.01\       19.94 ± 1.89\   5.29   0.040\*
  after ACTH\               (17.10-28.08)       (14.38-22.92)          
  stimulation (ug/dl)                                                  
  ------------------------------------------------------------------------------

Results are expressed as mean± SD and range, P \< 0.05\*: significant, ACTH: adrenocorticotropic hormone

![**Correlation between ACTH stimulated cortisol and autistic severity assessed by CARS**.](1824-7288-36-71-1){#F1}

Thirty three of our 50 autistic children (66%) had subnormal intellectual function (IQ below 70) among whom 25 (50%) had mild mental retardation (IQ = 50-69) and 8 (16%) had moderate mental retardation (IQ = 35-49). Of the 33 retarded patients, 20 (60.6%) had severe autism and the remaining 13 (39.4%) had mild to moderate autism. On comparing cortisol (basal and ACTH stimulated) & ACTH levels in relation to IQ of autistic patients, all hormonal parameters did not differ significantly according to the IQ of autistic children (p \> 0.05).

EEG abnormalities were found in 20/50 (40%) of autistic children (14 had severe autism and 6 had mild to moderate autism). These abnormalities included focal epileptogenic activity in frontal or temporal lobes in 10 patients, generalized epileptogenic activity in 6 patients and immature background in the remaining 4 patients. None of the hormones differed between autistic children with (n = 20) and without EEG abnormalities (n = 30, p \> 0.05).

Also, none of the hormones differed between autistic subjects with (n = 16) and without (n = 34) self-aggressive symptoms and among different Tanner stages (p \> 0.05).

Discussion
==========

Autism is a disorder of early childhood characterized by social impairment, communication abnormalities and stereotyped behaviours \[[@B23]\]. Inspite of the fact that many studies aimed at determining the neurobiological basis of this disorder, its cause remains obscure \[[@B21]\].

The limbic system deserves special attention in autism because this brain region is a basis for emotions and social interactions (which are abnormal in autism). Since the limbic system influences the functions of the hypothalamus and the pituitary gland, it is logical to postulate that analyzing blood levels of pituitary hormones may reflect possible alterations of the limbic system functioning in individuals with autism \[[@B29]\].

In the current study, serum cortisol levels were lower and plasma ACTH levels were higher in individuals with autism, compared to normal subjects with 10% and 16% having low cortisol and high ACTH respectively. In addition, 10% did not show adequate cortisol response to ACTH stimulation. Serum cortisol and ACTH levels were analyzed in several studies but the results were inconsistent. Marinovic-Curin and co-workers \[[@B21]\] found lower cortisol, higher ACTH and inadequate cortisol response after ACTH stimulation among their autistic patients in comparison to controls which goes with our results. Other studies that did not perform an ACTH stimulation test did not find a difference in cortisol levels among autistic patients and controls \[[@B22],[@B30]\] with only ACTH being significantly higher among cases than controls \[[@B30]\] or found significantly lower cortisol levels among autistic patients than controls \[[@B31]\]. In addition, Tani and associates \[[@B32]\] found lower cortisol and higher ACTH levels among patients with Asperger syndrome than controls. The difference between our findings and other studies could reflect variations in methods for hormone measurement. Also, our samples were collected in an earlier time period (9 am) and larger numbers of autistics and controls took part in our study compared to previous reports.

Cortisol has an important role in proper emotional development and functioning. Thus, abnormal cortisol levels were found in chronic depression and suicide prone behaviour \[[@B33]\]. In addition, lower levels of cortisol were found among holocaust victims with posttraumatic stress disorder and were pointer to \"vulnerability\" for its development \[[@B34]\]. Also, primary disorders of cortisol metabolism (Cushing syndrome and Addison disease), as well as cortisol supplement therapy are often associated with emotional disturbances \[[@B35]\]. Our finding of lower cortisol levels among individuals with autism is hard to interpret. Some authors hypothesized that individuals with autism display heightened response to stressors, namely venipuncture procedure so that anxiety and situational stress could explain the raised ACTH values \[[@B30]\] but elevated ACTH in our study was accompanied by lower cortisol levels which is in contradiction to such a conclusion. Also, the stress of venipuncture procedure was the same in both groups and so, the observed differences may be related to autism pathophysiology rather than to acute stress. There are many studies of the plasma levels of B-endorphin in autistic patients and most of them found higher levels of this hormone in individuals with autism \[[@B36]-[@B38]\]. Since ACTH and B-endorphin are secreted in equi-molar quantities from same precursor, pro-opiomelanocortin, from the anterior pituitary, other studies \[[@B30],[@B36]\] showing elevated B-endorphin levels in autistic individuals support our finding of elevated ACTH. Finally, we hypothesize that lower cortisol and higher ACTH levels may signal a state of low basal functioning of HPA axis in autistic individuals. This was confirmed in our study by failure of 10% of autistic patients to show an adequate cortisol response to ACTH stimulation which was supported by another study \[[@B21]\]. Suggested mechanisms include either an abnormality in delivery of ACTH to adrenal cortex receptors, or in biosynthesis of cortisol, or in negative feedback inhibition of HPA axis by cortisol and ACTH \[[@B30]-[@B32]\]. This hypothesis also, sheds light on the fact that HPA axis dysfunction might have a role in the pathophysiology of autism and its clinical symptomatology especially impaired behavioral and social interactions \[[@B21]\].

Moreover, the current study revealed significantly lower morning basal cortisol, higher ACTH and lower cortisol response after ACTH stimulation as the autistic severity increased. In addition, CARS score correlated positively with ACTH and negatively with each of basal and stimulated cortisol. This means that the extent of the HPA axis dysfunction was closely linked to autistic severity which was confirmed by another study \[[@B30]\].

In the current study, all hormonal parameters did not differ significantly according to the IQ of autistic subjects. Similarly, Marinovic-Curin etal, 2003 \[[@B21]\] and Tordjman etal 1997 \[[@B30]\] concluded that IQ itself did not appear to influence the hormonal levels significantly bearing in mind that they did not confirm their results by performing an ACTH stimulation test. To the best of our knowledge, we could not trace data in literature to explain the mechanism by which low plasma cortisol could affect cognitive functions in autistic children. On the other hand, another study \[[@B39]\] concluded that, generally speaking, increased cortisol levels due to stress-induced HPA axis over activity have been associated with cognitive impairment as stress-induced HPA axis overactivity and increased cortisol levels may cause hippocampal damage and, subsequently, cognitive decline. Furthermore, patients with Cushing\'s syndrome more often present with cognitive impairment \[[@B40]\]. Finally, one of the side-effects of treatment with synthetic corticosteroids is cognitive deterioration \[[@B41]\]

Also, the current study revealed that hormonal profile did not differ significantly between autistic children with and without EEG abnormalities which was also supported by Marinovic-Curin and associates \[[@B21]\].

In addition, the current study demonstrated that hormonal profile did not significantly differ between autistic patients with and without self injurious behavior which was also confirmed by another study \[[@B21]\]. Inspite of the previous fact, there is evidence of an association between low HPA axis activity and antisocial behavior since cortisol, which is the final product of the HPA axis, is an important factor for proper emotional and social development and functioning \[[@B42],[@B43]\].

Conclusions
===========

In conclusion, the observed hormonal changes may be due to a dysfunction in the HPA axis in autistic individuals. Further studies are warranted regarding the role of HPA axis dysfunction in the pathogenesis of autism.
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